Literature DB >> 11194030

Cell-mediated and humoral immunity and phagocytic ability in chicken Lines divergently selected for serum immunoglobulin M and G levels.

N Sarker1, M Tsudzuki, M Nishibori, H Yasue, Y Yamamoto.   

Abstract

Humoral and cell-mediated immunities and phagocytic ability were examined at the third and fourth generations of selection in two pairs of chicken lines (at 10 wk of age) that were divergently selected for levels of high serum Ig M (HIM), low serum Ig M (LIM), high serum Ig G (HIG), and low serum Ig G (LIG). Cell-mediated immunity was examined by splenomegaly assay at 12 wk of age. At 20 and 23 wk of age, 20 birds from the respective lines were injected Brucella abortus (BA), and blood samples were collected at 7 and 14 d postprimary immunization (PPI) and postsecondary immunization (PSI). Phagocytic ability was measured by carbon clearance assay at 25 and 30 wk of age. The results showed that the LIG line had higher degree of splenomegaly indices than the HIG line in both generations. The HIM and HIG lines had significantly (P < 0.05) higher total antibody titers to BA than their low counterparts. Similarly, mercaptoethanol-resistant (MER) antibody titers to BA, as measured only in the fourth generation, were significantly (P < 0.05) higher in the HIM and HIG lines than their low counterparts. In both generations, the HIM and HIG lines had significantly (P < 0.01) faster carbon clearance ability than the LIM and LIG lines. The results suggest that both pairs of selected lines exhibited divergence in immunocompetence, although they had been selected for serum Ig isotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11194030     DOI: 10.1093/ps/79.12.1705

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  7 in total

1.  Serum immunoglobulin G levels are positively related to reproductive performance in a long-lived seabird, the common tern (Sterna hirundo).

Authors:  Victor Apanius; Ian C T Nisbet
Journal:  Oecologia       Date:  2005-09-27       Impact factor: 3.225

2.  Type 1 and type 2 immune response profiles of commercial dairy cows in 4 regions across Canada.

Authors:  Kathleen A Thompson-Crispi; Bonnie A Mallard
Journal:  Can J Vet Res       Date:  2012-04       Impact factor: 1.310

3.  Mitigation potential of individual and combined dietary supplementation of local Bentonite Clay and Distillery Sludge against Ochratoxin-A induced toxicity in broilers.

Authors:  Mian Muhammad Awais; Ujala Mehtab; Muhammad Irfan Anwar; Muhammad Raza Hameed; Masood Akhtar; Ahmad Raza; Riffat Aisha; Faqir Muhammad; Muhammad Kashif Saleemi; Ahad Fayyaz
Journal:  BMC Vet Res       Date:  2022-10-19       Impact factor: 2.792

4.  Incidence rates of clinical mastitis among Canadian Holsteins classified as high, average, or low immune responders.

Authors:  Kathleen A Thompson-Crispi; Filippo Miglior; Bonnie A Mallard
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

5.  Assessment of trade-offs between feed efficiency, growth-related traits, and immune activity in experimental lines of layer chickens.

Authors:  Tatiana Zerjal; Sonja Härtle; David Gourichon; Vanaïque Guillory; Nicolas Bruneau; Denis Laloë; Marie-Hélène Pinard-van der Laan; Sascha Trapp; Bertrand Bed'hom; Pascale Quéré
Journal:  Genet Sel Evol       Date:  2021-05-06       Impact factor: 4.297

6.  Cytokines Expression and Nitric Oxide Production under Induced Infection to Salmonella Typhimurium in Chicken Lines Divergently Selected for Cutaneous Hypersensitivity.

Authors:  Rani Singh; Preeti Jain; N K Pandey; V K Saxena; M Saxena; K B Singh; K A Ahmed; R P Singh
Journal:  Asian-Australas J Anim Sci       Date:  2012-07       Impact factor: 2.509

7.  Influence of silver nanoparticles on growth and health of broiler chickens after infection with Campylobacter jejuni.

Authors:  Krishna Prasad Vadalasetty; Charlotte Lauridsen; Ricarda Margarete Engberg; Radhika Vadalasetty; Marta Kutwin; André Chwalibog; Ewa Sawosz
Journal:  BMC Vet Res       Date:  2018-01-02       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.